ANDA approved for Losartan Potassium Tablets USP, Losartan Potassium and Hydrochlorothiazide Tablets Roxane Laboratories, Inc. Announced today the approval of its Abbreviated New Medication Application for Losartan Potassium Tablets USP, 25mg, 50mg and 100mg as well as Losartan Hydrochlorothiazide and Potassium Tablets, 50mg/12.100mg/25mg and 5mg by the U.S. Food and Drug Administration. Both products are for sale to instant shipment to pharmacies and wholesalers nationwide.7 Million.This content was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family members Foundation. Kaiser Health News, an unbiased news service editorially, is a program of the Kaiser Family Foundation, a nonpartisan healthcare policy research company unaffiliated with Kaiser Permanente. a leader in senior treatment technology, today announced the addition of breakthrough technology for medication compliance within its in depth ActiveHome Monitoring System.